for a better and animal-free drug development
 

 

Mission

myofarm has developed a unique technology and process to analyse iPSC-derived macroscopic human myocard in unprecedented detail.

With this 3D in vitro model of the human heart muscle we support the global transformation to a more efficient and animal free drug development.

Team

Mariyam
Gaysaeva, B.Sc.

Lab & quality management

Andreas
Meyer-Borgstädt, MBA

Business development
& finance

Dr.-Ing. Jan Patrick Pietras, MBA

Engineering
& Life Sciences

Dr. rer. nat.
Hendrik Windel

Software, Hardware & Data-Science

Scientific
Advisor

Dr. rer. nat.
George Kensah

HEAD OF EXPERIMENTAL RESEARCH
DEPARTMENT OF THORACIC AND CARDIOVASCULAR SURGERY
UNIVERSITY MEDICAL CENTER GOETTINGEN (UMG)

Das Projekt myofarm wird im Rahmen des EXIST-Programms durch das Bundesministerium für Wirtschaft und Klimaschutz und den Europäischen Sozialfonds gefördert.

Stay in touch